Huntington National Bank’s Arena Pharmaceuticals Inc ARNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $101 | Hold |
2
| – | – | ﹤0.01% | 2606 |
|
|
2025
Q4 | $101 | Hold |
2
| – | – | ﹤0.01% | 2526 |
|
|
2025
Q3 | $101 | Hold |
2
| – | – | ﹤0.01% | 2616 |
|
|
2025
Q2 | $101 | Hold |
2
| – | – | ﹤0.01% | 2662 |
|
|
2025
Q1 | $101 | Hold |
2
| – | – | ﹤0.01% | 2699 |
|
|
2024
Q4 | $101 | Hold |
2
| – | – | ﹤0.01% | 2726 |
|
|
2024
Q3 | $101 | Hold |
2
| – | – | ﹤0.01% | 2722 |
|
|
2024
Q2 | $101 | Hold |
2
| – | – | ﹤0.01% | 2694 |
|
|
2024
Q1 | $101 | Hold |
2
| – | – | ﹤0.01% | 2510 |
|
|
2023
Q4 | $101 | Hold |
2
| – | – | ﹤0.01% | 2422 |
|
|
2023
Q3 | $101 | Hold |
2
| – | – | ﹤0.01% | 2407 |
|
|
2023
Q2 | $101 | Hold |
2
| – | – | ﹤0.01% | 2377 |
|
|
2023
Q1 | $101 | Hold |
2
| – | – | ﹤0.01% | 2212 |
|
|
2022
Q4 | $101 | Hold |
2
| – | – | ﹤0.01% | 2074 |
|
|
2022
Q3 | $0 | Hold |
2
| – | – | ﹤0.01% | 2551 |
|
|
2022
Q2 | $0 | Hold |
2
| – | – | ﹤0.01% | 2557 |
|
|
2022
Q1 | $0 | Sell |
2
-172
| -99% | -$16K | ﹤0.01% | 2480 |
|
|
2021
Q4 | $16K | Buy |
174
+44
| +34% | +$2.9K | ﹤0.01% | 1458 |
|
|
2021
Q3 | $8K | Buy |
130
+129
| +12,900% | +$7.62K | ﹤0.01% | 1508 |
|
|
2021
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 2029 |
|
|
2021
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 1921 |
|
|
2020
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 1896 |
|
|
2020
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 1844 |
|
|
2020
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 1851 |
|
|
2020
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 1945 |
|
|
2019
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 1957 |
|
|
2019
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 1864 |
|
|
2019
Q2 | $0 | Buy |
+1
| New | +$52 | ﹤0.01% | 1894 |
|
|
2019
Q1 | – | Sell |
-1
| Closed | – | – | 1889 |
|
|
2018
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 1952 |
|
|
2018
Q3 | $0 | Buy |
+1
| New | +$41 | ﹤0.01% | 1951 |
|
|
2016
Q2 | – | Sell |
-259
| Closed | -$11K | – | 1723 |
|
|
2016
Q1 | $11K | Buy |
+259
| New | +$4.15K | ﹤0.01% | 1454 |
|
|
2015
Q2 | – | Sell |
-259
| Closed | -$11K | – | 1844 |
|
|
2015
Q1 | $11K | Hold |
259
| – | – | ﹤0.01% | 1462 |
|
|
2014
Q4 | $9K | Buy |
+259
| New | +$10.5K | ﹤0.01% | 1470 |
|
|
2014
Q2 | – | Sell |
-4,000
| Closed | -$252K | – | 1115 |
|
|
2014
Q1 | $252K | Buy |
+4,000
| New | +$265K | ﹤0.01% | 1013 |
|
|
2013
Q4 | – | Sell |
-2,000
| Closed | -$105K | – | 1756 |
|
|
2013
Q3 | $105K | Sell |
2,000
-970
| -33% | -$65.1K | ﹤0.01% | 858 |
|
|
2013
Q2 | $229K | Buy |
+2,970
| New | +$242K | 0.01% | 608 |
|
Huntington National Bank's ARNA Position: Q1 2026 in Review
Huntington National Bank held its Arena Pharmaceuticals Inc (ARNA) position steady in Q1 2026 at 2 shares worth $101. The position accounts for ﹤0.01% of the portfolio, ranked #2606.
Huntington National Bank first reported a position in ARNA in Q2 2013 and has held it in 36 quarters since. The position peaked at $252K in Q1 2014. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2026.
- Huntington National Bank held 2 shares of Arena Pharmaceuticals Inc worth $101 as of Q1 2026.
- Huntington National Bank left its Arena Pharmaceuticals Inc share count unchanged in Q1 2026.
- Arena Pharmaceuticals Inc made up ﹤0.01% of Huntington National Bank's portfolio in Q1 2026, its #2606 holding.
- Huntington National Bank first reported a position in Arena Pharmaceuticals Inc in Q2 2013 and has held it in 36 quarters since.
- Huntington National Bank's Arena Pharmaceuticals Inc position peaked at $252K in Q1 2014.
- 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2026.
Based on Huntington National Bank's 13F filing for Q1 2026, filed 15 May 2026.